REQUEST A DEMO
Total
USD $0.00
Search more companies

Smc Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Periodical Publishers | Lessors of Real Estate | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | General Medical and Surgical Hospitals | Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
Full name: Smc Pharma Sp. z o.o. Profile Updated: May 06, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Smc Pharma Sp. z o.o. is an enterprise in Poland, with the main office in Krakow. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 28, 2012. 1 (2015) employees currently work for Smc Pharma Sp. z o.o.. Over the same period, its total assets decreased by 33.21%.

Headquarters
Ul. Al. Mickiewicza 21
Krakow; Malopolskie; Postal Code: 31-120

Contact Details: Purchase the Smc Pharma Sp. z o.o. report to view the information.

Website: http://smcpharma.pl/

Basic Information
Total Employees:
Purchase the Smc Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Smc Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Smc Pharma Sp. z o.o. report to view the information.
Incorporation Date:
May 28, 2012
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Smc Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net Profit/Loss for the Period
80.56%
Total Assets
-33.21%
Total Equity
-0.24%
Return on Equity (ROE)
-0.98%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?